Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-07-029806
Filing Date
2007-05-14
Accepted
2007-05-14 11:44:20
Documents
1
Period of Report
2007-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3784
  Complete submission text file 0001209191-07-029806.txt   5624
Mailing Address 22026 20TH AVENUE SE, SUITE 102 BOTHELL WA 98021
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address SONUS PHAMACEUTICALS INC 22026 20TH AVE SE BOTHELL WA 98021
Business Address 4254879500
WINSTEAD DWIGHT (Reporting) CIK: 0001244331 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21243 | Film No.: 07844805